Third-generation irreversible EGFR-TKI, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, CNS metastasis activity, for EGFRm NSCLC patients,
Sale!
Lucius
Replica: Osimertinib EGFRm NSCLC Targeted Therapy
Original price was: $698.00.$539.00Current price is: $539.00.
Third-generation irreversible EGFR-TKI, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, CNS metastasis activity, for EGFRm NSCLC patients,
Reviews
There are no reviews yet.